Cabe,
How is this anything but positive news? Stage 2 Audit completion could be as short at 1 month, which having had a predicate device already approved with CE mark may be the case. The path to market has some key steps to it and those steps are being achieved. Whether it's 3 months - 6 months one would suggest that if those steps are critical to a highly successful launch and acceptance by the medical community, then they should be conducted at the highest standard, with the utmost rigour to ensure the very best product/platform, supported by the best people is going out to the users who need it.
Cabe,How is this anything but positive news? Stage 2 Audit...
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RSH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $38.54M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 800000 | 2.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.0¢ | 508500 | 3 |
View Market Depth
| Last trade - 16.12pm 11/09/2024 (20 minute delay) ? |
| RSH (ASX) Chart |
Day chart unavailable